Home > > > > > Report Detail

Diarrhea and Constipation Drug Development Pipeline Review, 2018

Publisher Name :
Date: 30-Jul-2018
No. of pages: 93

Diarrhea and Constipation Drug Development Pipeline Review, 2018

Summary

This report provides an overview of the pipeline landscape for diarrhea and constipation. It provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for diarrhea and constipation, and features dormant and discontinued products.

Diarrhea is a contagious gastrointestinal infection occurring mostly due to unhygienic conditions. Diarrhea may be related to a viral or bacterial infection and is sometimes the result of food poisoning. Symptoms include nausea, abdominal pain, cramping, bloating, dehydration, fever, bloody stools, frequent urge to evacuate the bowels and incontinence. There are 54 products in development for this indication and molecular targets present in the pipeline landscape include cystic fibrosis transmembrane conductance regulator and glucagon like peptide 2 receptor.

Constipation refers to the infrequent or difficult passing of stool. Constipation occurs when bowel movements become difficult or less frequent. Symptoms of constipation include swollen abdomen or abdominal pain, pain and vomiting.

The predisposing factors include eating disorders, irritable bowel syndrome, and hypothyroidism, overuse of laxatives (stool softeners) which, over time, weaken the bowel muscles, stress, inadequate water intake and inadequate fiber in the diet. There are 25 products in development for this indication and molecular targets present in the pipeline landscape include 5-hydroxytryptamine receptor 4 and heat stable enterotoxin receptor.

Companies operating in this pipeline space include Synthetic Biologics, Allergan and Ardelyx.

Scope

- Which companies are the most active within each pipeline?

- Which pharmaceutical approaches are the most prominent at each stage of the pipeline and within each indication?

- To what extent do universities and institutions play a role within this pipeline, compared to pharmaceutical companies?

- What are the most important R&D milestones and data publications to have happened in this disease area?

Reasons to buy

- Understand the overall pipeline, with an at-a-glance overview of all products in therapeutic development for each indication

- Assess the products in development in granular detail, with an up-to-date overview of each individual pipeline program in each indication and a comprehensive picture of recent updates and milestones for each

- Analyze the companies, institutions and universities currently operating in the pipeline and the products being fielded by each of these

- Understand the composition of the pipeline in terms of molecule type, molecular target, mechanism of action and route of administration

Diarrhea and Constipation Drug Development Pipeline Review, 2018

1 Table of Contents
1 Table of Contents 4
1.1 List of Tables 5
1.2 List of Figures 6
2 Introduction 7
2.1 Diarrhea and Constipation Report Coverage 7
2.2 Constipation - Overview 7
2.3 Diarrhea - Overview 7
3 Therapeutics Development 8
3.1 Constipation 8
3.2 Diarrhea 13
4 Therapeutics Assessment 20
4.1 Constipation 20
4.2 Diarrhea 26
5 Companies Involved in Therapeutics Development 33
5.1 Constipation 33
5.2 Diarrhea 41
6 Dormant Projects 57
6.1 Constipation 57
6.2 Diarrhea 58
7 Discontinued Products 61
7.1 Constipation 61
7.2 Diarrhea 61
8 Product Development Milestones 62
8.1 Constipation 62
8.2 Diarrhea 78
9 Appendix 92
9.1 Methodology 92
9.2 Coverage 92
9.3 Secondary Research 92
9.4 Primary Research 92
9.5 Expert Panel Validation 92
9.6 Contact Us 93
9.7 Disclaimer 93

1.1 List of Tables
Table 1: Number of Products under Development for Constipation 8
Table 2: Number of Products under Development by Companies, Constipation 10
Table 3: Number of Products under Development by Universities/Institutes, Constipation 11
Table 4: Products under Development by Companies, Constipation 12
Table 5: Products under Development by Universities/Institutes, Constipation 13
Table 6: Number of Products under Development for Diarrhea 13
Table 7: Number of Products under Development by Companies, Diarrhea 14
Table 8: Number of Products under Development by Universities/Institutes, Diarrhea 16
Table 9: Products under Development by Companies, Diarrhea 17
Table 10: Products under Development by Universities/Institutes, Diarrhea 19
Table 11: Number of Products by Stage and Target, Constipation 21
Table 12: Number of Products by Stage and Mechanism of Action, Constipation 22
Table 13: Number of Products by Stage and Route of Administration, Constipation 24
Table 14: Number of Products by Stage and Molecule Type, Constipation 25
Table 15: Number of Products by Stage and Target, Diarrhea 27
Table 16: Number of Products by Stage and Mechanism of Action, Diarrhea 29
Table 17: Number of Products by Stage and Route of Administration, Diarrhea 31
Table 18: Number of Products by Stage and Molecule Type, Diarrhea 32
Table 19: Constipation - Pipeline by Allergan Plc 33
Table 20: Constipation - Pipeline by Ardelyx Inc 33
Table 21: Constipation - Pipeline by Braintree Laboratories Inc 34
Table 22: Constipation - Pipeline by Dong-A ST Co Ltd 34
Table 23: Constipation - Pipeline by EA Pharma Co Ltd 35
Table 24: Constipation - Pipeline by Ironwood Pharmaceuticals Inc 35
Table 25: Constipation - Pipeline by Johnson & Johnson 36
Table 26: Constipation - Pipeline by MallInckrodt Plc 37
Table 27: Constipation - Pipeline by NGM Biopharmaceuticals Inc 37
Table 28: Constipation - Pipeline by RaQualia Pharma Inc 38
Table 29: Constipation - Pipeline by Sanwa Kagaku Kenkyusho Co Ltd 38
Table 30: Constipation - Pipeline by SK Biopharmaceuticals Co Ltd 38
Table 31: Constipation - Pipeline by Sumitomo Dainippon Pharma Co Ltd 39
Table 32: Constipation - Pipeline by Synthetic Biologics Inc 39
Table 33: Constipation - Pipeline by Vanda Pharmaceuticals Inc 40
Table 34: Constipation - Pipeline by Yuhan Corp 40
Table 35: Constipation - Pipeline by Zensun (Shanghai) Sci & Tech Co Ltd 41
Table 36: Diarrhea - Pipeline by Aegis Therapeutics LLC 41
Table 37: Diarrhea - Pipeline by Akthelia Pharmaceuticals Ltd 42
Table 38: Diarrhea - Pipeline by Albireo Pharma Inc 42
Table 39: Diarrhea - Pipeline by Allergan Plc 43
Table 40: Diarrhea - Pipeline by Ardelyx Inc 43
Table 41: Diarrhea - Pipeline by AzurRx BioPharma Inc 43
Table 42: Diarrhea - Pipeline by Bharat Biotech Ltd 44
Table 43: Diarrhea - Pipeline by Chongqing Zhifei Biological Products Co Ltd 44
Table 44: Diarrhea - Pipeline by Cosmo Pharmaceuticals NV 45
Table 45: Diarrhea - Pipeline by DiscoveryBiomed Inc 45
Table 46: Diarrhea - Pipeline by Ferring International Center SA 46
Table 47: Diarrhea - Pipeline by GP Pharm SA 46
Table 48: Diarrhea - Pipeline by Kuhnil Pharmaceutical Co Ltd 47
Table 49: Diarrhea - Pipeline by Metacrine Inc 47
Table 50: Diarrhea - Pipeline by Miyarisan Pharmaceutical Company Ltd 48
Table 51: Diarrhea - Pipeline by Napo Pharmaceuticals Inc 48
Table 52: Diarrhea - Pipeline by Nippon Shinyaku Co Ltd 49
Table 53: Diarrhea - Pipeline by Novartis AG 49
Table 54: Diarrhea - Pipeline by Pfizer Inc 50
Table 55: Diarrhea - Pipeline by Prokarium Ltd 50
Table 56: Diarrhea - Pipeline by Protagonist Therapeutics Inc 51
Table 57: Diarrhea - Pipeline by RaQualia Pharma Inc 51
Table 58: Diarrhea - Pipeline by RedHill Biopharma Ltd 52
Table 59: Diarrhea - Pipeline by RxBio Inc 52
Table 60: Diarrhea - Pipeline by Scandinavian Biopharma Holding AB 53

1.2 List of Figures
Figure 1: Number of Products under Development for Constipation 8
Figure 2: Number of Products under Development by Companies, Constipation 9
Figure 3: Number of Products under Development for Diarrhea 13
Figure 4: Number of Products under Development by Companies, Diarrhea 14
Figure 5: Number of Products under Development by Universities/Institutes, Diarrhea 16
Figure 6: Number of Products by Targets, Constipation 20
Figure 7: Number of Products by Stage and Targets, Constipation 20
Figure 8: Number of Products by Top 10 Mechanism of Actions, Constipation 21
Figure 9: Number of Products by Stage and Top 10 Mechanism of Actions, Constipation 22
Figure 10: Number of Products by Routes of Administration, Constipation 23
Figure 11: Number of Products by Stage and Routes of Administration, Constipation 23
Figure 12: Number of Products by Molecule Types, Constipation 24
Figure 13: Number of Products by Stage and Molecule Types, Constipation 25
Figure 14: Number of Products by Top 10 Targets, Diarrhea 26
Figure 15: Number of Products by Stage and Top 10 Targets, Diarrhea 26
Figure 16: Number of Products by Top 10 Mechanism of Actions, Diarrhea 28
Figure 17: Number of Products by Stage and Top 10 Mechanism of Actions, Diarrhea 28
Figure 18: Number of Products by Routes of Administration, Diarrhea 30
Figure 19: Number of Products by Stage and Routes of Administration, Diarrhea 30
Figure 20: Number of Products by Top 10 Molecule Types, Diarrhea 31
Figure 21: Number of Products by Stage and Top 10 Molecule Types, Diarrhea 32
  • Global Anti-Peptic Ulcer Drugs Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 110
    According to our LPI (LP Information) latest study, the global Anti-Peptic Ulcer Drugs market size was valued at US$ 8523.5 million in 2023. With growing demand in downstream market, the Anti-Peptic Ulcer Drugs is forecast to a readjusted size of US$ 21200 million by 2030 with a CAGR of 13.9% during review period. The research report highlights the growth potential of the global Anti-Peptic Ulcer Drugs market. Anti-Peptic Ulcer Drugs are expected to show stable growth in the future marke......
  • Global Lansoprazole Market Research Report 2024
    Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 102
    The Lansoprazole market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Lansoprazole market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the comp......
  • Global Irritable Bowel Syndrome (IBS) Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 88
    According to our LPI (LP Information) latest study, the global Irritable Bowel Syndrome (IBS) market size was valued at US$ 4634.2 million in 2023. With growing demand in downstream market, the Irritable Bowel Syndrome (IBS) is forecast to a readjusted size of US$ 12750 million by 2030 with a CAGR of 15.6% during review period. The research report highlights the growth potential of the global Irritable Bowel Syndrome (IBS) market. Irritable Bowel Syndrome (IBS) are expected to show stabl......
  • Global Esomeprazole Market Research Report 2024
    Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 89
    The Esomeprazole market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Esomeprazole market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the comp......
  • Global Irritable Bowel Syndrome (IBS) Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 02-Jan-2024        Price: US 3380 Onwards        Pages: 126
    Market Overview of Global Irritable Bowel Syndrome (IBS) market: According to our latest research, the global Irritable Bowel Syndrome (IBS) market looks promising in the next 5 years. As of 2022, the global Irritable Bowel Syndrome (IBS) market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive anal......
  • Global Diarrhea Drug Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 28-Dec-2023        Price: US 3380 Onwards        Pages: 109
    Market Overview of Global Diarrhea Drug market: According to our latest research, the global Diarrhea Drug market looks promising in the next 5 years. As of 2022, the global Diarrhea Drug market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Diarrhea Drug market, with a sys......
  • Drugs for Traveler's Diarrhea - Global Market Insights and Sales Trends 2024
    Published: 27-Dec-2023        Price: US 3350 Onwards        Pages: 96
    This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking By Company; 3) comprehensive presentation of the global market for Drugs for Traveler's Diarrhea, with bo......
  • Global Lansoprazole Professional Survey Report 2023, Forecast to 2028
    Published: 26-Dec-2023        Price: US 3280 Onwards        Pages: 136
    Lansoprazole reduces the amount of acid your stomach makes. It's used for indigestion, heartburn and acid reflux and gastroesophageal-reflux-disease (GORD). Lansoprazole is also taken to prevent and treat stomach ulcers. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their g......
  • Global Pentasa (Ulcerative Colitis) Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 113
    Market Overview of Global Pentasa (Ulcerative Colitis) market: According to our latest research, the global Pentasa (Ulcerative Colitis) market looks promising in the next 5 years. As of 2022, the global Pentasa (Ulcerative Colitis) market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis o......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs